FR2954164B1 - Composition antifongique destinee a etre appliquee sur l'ongle perfore - Google Patents

Composition antifongique destinee a etre appliquee sur l'ongle perfore

Info

Publication number
FR2954164B1
FR2954164B1 FR0959186A FR0959186A FR2954164B1 FR 2954164 B1 FR2954164 B1 FR 2954164B1 FR 0959186 A FR0959186 A FR 0959186A FR 0959186 A FR0959186 A FR 0959186A FR 2954164 B1 FR2954164 B1 FR 2954164B1
Authority
FR
France
Prior art keywords
composition intended
antifungal composition
perforated nail
nail
perforated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0959186A
Other languages
English (en)
Other versions
FR2954164A1 (fr
Inventor
Nathalie Willcox
Claire Mallard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma Pharma SA
Original Assignee
Galderma Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Pharma SA filed Critical Galderma Pharma SA
Priority to FR0959186A priority Critical patent/FR2954164B1/fr
Priority to PCT/EP2010/070086 priority patent/WO2011073395A1/fr
Priority to CA 2783891 priority patent/CA2783891A1/fr
Priority to JP2012543791A priority patent/JP2013514334A/ja
Priority to EP10790453A priority patent/EP2512447A1/fr
Priority to US13/516,962 priority patent/US20120309763A1/en
Publication of FR2954164A1 publication Critical patent/FR2954164A1/fr
Application granted granted Critical
Publication of FR2954164B1 publication Critical patent/FR2954164B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR0959186A 2009-12-18 2009-12-18 Composition antifongique destinee a etre appliquee sur l'ongle perfore Expired - Fee Related FR2954164B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR0959186A FR2954164B1 (fr) 2009-12-18 2009-12-18 Composition antifongique destinee a etre appliquee sur l'ongle perfore
PCT/EP2010/070086 WO2011073395A1 (fr) 2009-12-18 2010-12-17 Composition antifongique destinée à être appliquée sur un ongle perforé
CA 2783891 CA2783891A1 (fr) 2009-12-18 2010-12-17 Composition antifongique destinee a etre appliquee sur un ongle perfore
JP2012543791A JP2013514334A (ja) 2009-12-18 2010-12-17 穿孔爪への適用を意図する抗真菌組成物
EP10790453A EP2512447A1 (fr) 2009-12-18 2010-12-17 Composition antifongique destinée à être appliquée sur un ongle perforé
US13/516,962 US20120309763A1 (en) 2009-12-18 2010-12-17 Antifungal composition intended to be applied to a perforated nail

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0959186A FR2954164B1 (fr) 2009-12-18 2009-12-18 Composition antifongique destinee a etre appliquee sur l'ongle perfore

Publications (2)

Publication Number Publication Date
FR2954164A1 FR2954164A1 (fr) 2011-06-24
FR2954164B1 true FR2954164B1 (fr) 2012-03-16

Family

ID=42112141

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0959186A Expired - Fee Related FR2954164B1 (fr) 2009-12-18 2009-12-18 Composition antifongique destinee a etre appliquee sur l'ongle perfore

Country Status (6)

Country Link
US (1) US20120309763A1 (fr)
EP (1) EP2512447A1 (fr)
JP (1) JP2013514334A (fr)
CA (1) CA2783891A1 (fr)
FR (1) FR2954164B1 (fr)
WO (1) WO2011073395A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090175810A1 (en) 2008-01-03 2009-07-09 Gareth Winckle Compositions and methods for treating diseases of the nail
US8039494B1 (en) 2010-07-08 2011-10-18 Dow Pharmaceutical Sciences, Inc. Compositions and methods for treating diseases of the nail
EP2838569A1 (fr) * 2012-04-20 2015-02-25 Galderma Research & Development Optimisation d'un traitement des ongles par autoradiographie quantitative
US9433680B2 (en) 2013-01-31 2016-09-06 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9452173B2 (en) 2013-01-31 2016-09-27 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9446131B2 (en) 2013-01-31 2016-09-20 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US8778365B1 (en) 2013-01-31 2014-07-15 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
MY179756A (en) 2013-10-03 2020-11-12 Dow Pharmaceutical Sciences Stabilized efinaconazole formulations
CN112999223A (zh) 2013-11-22 2021-06-22 博世健康爱尔兰有限公司 抗感染的方法、组合物和装置
JP6570316B2 (ja) * 2015-05-25 2019-09-04 ロート製薬株式会社 爪用組成物
GB201710491D0 (en) * 2017-06-30 2017-08-16 Blueberry Therapeutics Ltd Composition and methods of treatment
EP4041839A4 (fr) * 2019-10-08 2023-10-11 Hallux, Inc. Compositions et procédés de traitement de l'onychomycose

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0019283D0 (en) * 2000-08-04 2000-09-27 Novartis Ag Organic compounds
WO2004086938A2 (fr) 2003-03-25 2004-10-14 Herndon Terry O Dispositif de perforation et procede servant a creer des conduits microscopiques
EP1627610A1 (fr) 2004-08-21 2006-02-22 TLT Medical Ltd Administration de médicaments par application dans des ongles
KR20080098596A (ko) * 2006-01-02 2008-11-11 티엘티 메디컬 리미티드 조갑 질환 치료용 약학적 조성물
WO2009132343A1 (fr) * 2008-04-25 2009-10-29 Nanobio Corporation Nanoemulsions destinées à traiter l'onychomycose

Also Published As

Publication number Publication date
WO2011073395A1 (fr) 2011-06-23
JP2013514334A (ja) 2013-04-25
EP2512447A1 (fr) 2012-10-24
CA2783891A1 (fr) 2011-06-23
US20120309763A1 (en) 2012-12-06
FR2954164A1 (fr) 2011-06-24

Similar Documents

Publication Publication Date Title
FR2954164B1 (fr) Composition antifongique destinee a etre appliquee sur l'ongle perfore
ATE478018T1 (de) Verschluss zum anzeige einer paketintegrität
BRPI1006415A2 (pt) "método para controlar fungos nocivos"
BRPI0817538A2 (pt) Composição cosmética ou farmacêutica, a ser aplicada topicamente
BRPI0913806A2 (pt) "composição"
BRPI0916123A2 (pt) "composição de xampu concentrada"
BRPI0906534A2 (pt) "dispositivo para impedir a circulação de veículos"
FI20065813L (fi) Työkoneeseen kiinnitettävä paalipihti
BRPI0916129A2 (pt) "reforço"
FR2944501B1 (fr) Balai d'essuie-glace
FR2913705B1 (fr) Poignee de couteau a enduire.
BRPI0914503A2 (pt) "composição de shampoo concentrado"
BRPI0819070A2 (pt) "composição energética comestível"
FR2951936B1 (fr) Dispositif a appliquer sur la peau.
DK2069255T3 (da) Byggemateriale med plantefyldstof
BRPI0905660A2 (pt) "método para reduzir ou inibir a angiogênese"
FR2921561B1 (fr) Composition cosmetique destinee a ameliorer l'etat de peau
BRPI0916092A2 (pt) "isoformas específicas de anticorpos anti-her4"
MA30860B1 (fr) Myrtillier denomme "c97-390"
ITTS20080001U1 (it) Ventosa che puo' essere rimossa facilemente e rapidamente.
FR2919553B1 (fr) Balai d'essuie-glace
FI20080124A0 (fi) Läheis-Josephson-ilmaisin
EE00792U1 (et) Katusekattematerjal
FI20070356A0 (fi) Pystykarsintakorjuu ja laite sen toteuttamiseksi
FR2956714B1 (fr) Organe d'absorption d'energie, notamment pour structures devant retenir les eboulements

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20140829